Mumbai, April 16, 2015 – Sun Pharmaceutical Industries and the Technion–Israel institute of technology have entered into an exclusive worldwide research and licence agreement for the development of novel anti-cancer drugs.
The joint project would be based on new findings by Nobel Prize laureate Professor Aaron Ciechanover, Gila Maor and Professor Ofer Binah, a note from Sun Pharma said.
The research development comes weeks after Sun sealed its $4-billion deal to merge troubled drugmaker Ranbaxy.
The institute’s pre-clinical research was funded this far by Dr Alfred Mann. The Technion and Sun Pharma alliance will advance this project through pre-clinical development process, said Ciechanover and Binah, adding that they had explored several alternatives in the past.
Business Line
By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…
By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …
Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…
New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…
Dr Agarwals Eye Hospital, Bengaluru, is providing free consultations for diabetic patients aged 50 and…
By Ms. Archana S, Senior Nutritionist, Aster Whitefield Hospital, Bengaluru As an essential nutrient, protein…